ChartRow logo
Share this page
RCUS
$22.12-3.07%
as of close, Oct 16, 2026
☾ AH $22.12 -3.07%
Arcus Biosciences Inc.Stock · HealthcareRussell 2000 0.09%US Stock Market 0.004%Russell 3000 0.003%
PeersMRNALLYMDTUNHJNJTMO

Arcus Biosciences Inc. trailing returns

How Arcus Biosciences Inc. (RCUS) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-3.1%+0.0%-3.1%—
5 days-9.4%+0.0%-9.4%-9.4%Oct 16
1 month-10.3%+0.0%-10.3%-17.7%Oct 16
YTD-7.2%+0.0%-7.2%-29.9%Oct 16
1 year+33.3%+0.0%+33.3%-29.9%Oct 2026
5 years-8.4%+0.0%-8.4%-35.7%-85.8%Apr 2025
Since inception (2018)+3.1%+0.0%+3.1%+30.1%-85.8%Apr 2025

Growth of RCUS#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years-8.4%/year · -35.7%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in RCUS's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Arcus Biosciences Inc.'s return since inception?
Since 2018, Arcus Biosciences Inc. (RCUS) has compounded at about +3.1% a year — +30.1% in total.

More on Arcus Biosciences Inc.